Orchid Chemicals & Pharmaceuticals Limited is an Indian pharmaceutical company based in Chennai, founded on 1 July 1992 by Kailasam Raghavendra Rao. Orchid’s main products are active pharmaceutical ingredients, including cephalosporins (oral and injectable), carbapenems and penicillin. The other main production is domestic formulations for cardio, anti-diabetic, neuropsychiatry, and critical care applications.Orchid Pharma securities are traded at NSE, BSE, MSE, and Singapore Stock Exchange.
Nuvama Wealth Management Limited has successfully closed a transaction of c.INR 4,000mn (US$48mn) as the Left Lead Banker to Orchid Pharma for its successful equity fund raise. QIP helped in achieving dual objectives of funding the company’s Capex plans as well as help in achieving Minimum Public Shareholding (MPS) norms. With this QIP, Nuvama has successfully closed the 2nd transaction for Orchid Pharma.
Nuvama Investment Banking
Advised in the sale of
Orchid Pharma
to